Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2024 Earnings Call Transcript
Operator: Thank you for standing by and welcome to Heron Therapeutics Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Posts Tagged ‘NASDAQ:HRTX’
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name is Jermaine, and I will be your conference operator today.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.0209, expectations were $-0.08.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2023 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Heron Therapeutics Fourth Quarter 2023 Conference Call.
12 Best Rising Penny Stocks To Buy
In this article, we will take a detailed look at the 12 Best Rising Penny Stocks To Buy. For a quick overview of such stocks, read our article 5 Best Rising Penny Stocks ...
Hedge Funds Say These 5 Penny Stocks are Poised to Explode
Below you can find the list of 5 penny stocks that are poised to explode according to hedge funds.
13 Hot Penny Stocks To Buy According to Hedge Funds
In this article, we will take a look at the 13 Hot Penny Stocks To Buy According to Hedge Funds.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q3 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q3 2023 Earnings Conference Call.
11 Best Long-Term Penny Stocks to Buy Now
The Federal Reserve’s historic battle against inflation that started in 2022 has highlighted the importance of an already-known fact: if you want to beat inflation always invest...
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q1 2023 Earnings Conference.
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Heron Therapeutics Fourth Quarter 2022 Earnings Conference.
15 Most Shorted Stocks Hedge Funds Are Buying
In this article, we will discuss the 15 most shorted stocks hedge funds are buying.
12 Best Affordable Stocks to Buy Under $5
Third Point, a New York-based financial advisor, published its third-quarter 2022 investor letter back in October, in which the fund highlighted its market outlook.
10 Most Shorted Stocks in September
In this article, we discuss the 10 most shorted stocks to watch in September.
5 WallStreetBets Stocks Gaining in August
In this article, we discuss 5 WallStreetBets stocks that are gaining in August.
5 Most Shorted Stocks to Watch in July
In this article, we discuss the 5 most shorted stocks to watch in July.
5 Most Shorted Stocks to Watch
In this article, we will discuss the 5 most shorted stocks to watch today.
Short Sellers Are Targeting These 10 Stocks
In this article, we will be discussing 10 stocks that short sellers are targeting.
Short Sellers Were Right About These 10 Stocks
In this article, we discuss the 10 stocks that short sellers were right about.
10 Growth Stocks Under $20 in Billionaire Ken Fisher’s Portfolio
In this article, we discuss the 10 growth stocks under $20 in billionaire Ken Fisher's portfolio.
Is HRTX A Good Stock To Buy According To Hedge Funds?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Heron Therapeutics Inc (HRTX): Hedge Funds Are Nibbling
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Heron Therapeutics Inc (HRTX) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here is What Hedge Funds Think About Heron Therapeutics Inc (HRTX)
In this article you are going to find out whether hedge funds think Heron Therapeutics Inc (NASDAQ:HRTX) is a good investment right now.
Do Hedge Funds Love Heron Therapeutics Inc (HRTX)?
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
Hedge Funds Cashed Out Of Heron Therapeutics Inc (HRTX) Too Early
Many investors, including Paul Tudor Jones or Stan Druckenmiller, have been saying before last year's Q4 market crash that the stock market is overvalued due to a low interest...
Is Heron Therapeutics Inc (HRTX) Going to Burn These Hedge Funds?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Hedge Funds Have Never Been More Bullish On Heron Therapeutics Inc (HRTX)
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Here’s What Hedge Funds Think About Heron Therapeutics Inc (HRTX)
While the market driven by short-term sentiment influenced by uncertainty regarding the future of the interest rate environment in the US, declining oil prices and the trade war...
Hedge Funds Are Buying Heron Therapeutics Inc (HRTX)
A whopping number of 13F filings filed with U.S.
Hedge Fund and Insider Trading News: Bridgewater Associates, Winton Capital, Heron Therapeutics Inc (HRTX), Accuray Incorporated (ARAY), and More
SHANGHAI (Reuters) - Renowned global hedge fund managers Bridgewater Associates LP and Winton Group Ltd have had registrations to launch products in China accepted at a time of...
Hedge Fund and Insider Trading News: Folger Hill Asset Management, Starboard Value LP, Unum Therapeutics Inc (UMRX), Spectrum Pharmaceuticals, Inc. (SPPI), Trinity Industries Inc (TRN), and More
Hedge fund Folger Hill Asset Management is merging with Schonfeld Strategic Advisors and returning capital to certain investors in May, according to an investor letter sent Tuesday...
Hedge Fund and Insider Trading News: D.E. Shaw, Appaloosa Management, Bill Ackman, Arcus Biosciences Inc (RCUS), SCYNEXIS Inc (SCYX), RealNetworks Inc (RNWK), and More
Several prominent hedge funds could be among investors feeling the pain from Facebook Inc.’s recent plunge amid the Cambridge Analytica data crisis.
Market Movers Today: Facebook, Inc. (FB), Geron Corporation (GERN), Heron Therapeutics Inc (HRTX), Micro Focus International PLC – ADR (MFGP), and More
Facebook Inc.'s stock tumbled Monday after the social media company accused a data analytics firm used by the Trump campaign of exploiting ill-gotten data belonging to unwitting...
Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN
In new guidelines, Heron Therapeutics Inc (NASDAQ:HRTX) has announced that Sustol will be included as an extended-release injection.
Legendary Railroad Executive Offloads Huge Amount of Shares After Announcing Decision to Retire from Canadian Pacific Railway, Plus Other Insider Trading
Assuming corporate insiders know a lot more about their company’s prospects and recent developments than any of us, which they do, investors would be wise to keep a close eye...
Is Heron Therapeutics Inc (HRTX) a Good Stock To Buy?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
Here’s Why TASER International, Heron Therapeutics and Three Other Stocks Are Trading Lower on Monday
The markets have opened the fourth quarter on a negative note.
What’s In The Latest Heron Therapeutics Inc (HRTX) Data?
Heron Therapeutics Inc (NASDAQ:HRTX) just announced topline from its two lead pain management phase II trials.
Healthcare-Focused Broadfin Capital’s Notable Moves Include Cardiovascular Systems, Nevro Corp & Others
Kevin Kotler's healthcare-focused fund Broadfin Capital held a 13F portfolio valued at about $1.04 billion at the end of the first quarter, according to its latest filing.
Why Are Investors Piling Into These 5 Surging Stocks?
It's a day of diverging indexes as the S&P 500 is up by 0.37% while the NASDAQ is down by 0.20%.
Heron Therapeutics, Inc. (HRTX): Tang Capital Partners Raises Stake to 17%
According to a newly-amended 13D filing with the US SEC, Kevin C.
Kevin Kotler’s Healthcare Fund Broadfin Capital Just Had A Disastrous Q1
Though 2016 hasn't been great for the overall hedge fund industry so far, it is turning out to be an especially terrible year for biotech-focused hedge funds.
Venrock’s VHCP Management’s Top Picks For 2016
At Insider Monkey, we look at the weighted average returns of the long positions a fund indicates in its 13F filings, in companies with a market cap greater than $1 billion, ...
Hedge Funds Are Hoarding Shares Of Heron Therapeutics Inc (HRTX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
VHCP Management Produced Impressive Returns From Its Pharma Stock Picks In The Turbulent Third Quarter
With losses in the high single-digits and volatility hitting the roof, the third quarter of 2015 turned out to be a troublesome period for the equity markets.
Three Biotech Stocks Are Down Today but Hedge Funds Say They Are Not Out
Shares of ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Intrexon Corp (NYSE:XON), and Heron Therapeutics Inc (NASDAQ:HRTX) are down significantly today amid a broader market decline.
These Biotech Stocks Move in Opposing Directions Today and Hedge Funds Say You Should Bet on One of Them
Shares of Heron Therapeutics Inc (NASDAQ:HRTX) are up by more than 20% in early trading, following positive Phase 2 reports on HTX-011, an anesthetic and anti-inflammatory ...
